Pigment epithelial-derived factor inhibits c-FLIP expression and assists ciglitazone-induced apoptosis in

Li-Ju Lai1, Tsung-Chuan Ho

  • 1Department of Ophthalmology, Chang Gang Memorial Hospital, Chia-Yi County, Taiwan, Republic of China.

Anticancer Research
|April 22, 2011
PubMed
Abstract

Insights

Pigment epithelial-derived factor (PEDF) reduces cellular FLICE-inhibitory protein (c-FLIP) in hepatoma cells via p38 kinase signaling. This finding suggests PEDF enhances apoptotic activity in liver cancer cells.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Pigment epithelial-derived factor (PEDF) exhibits antiangiogenic properties partly by suppressing cellular FADD-like IL-1β-converting enzyme (FLICE)/caspase-8-inhibitory protein (c-FLIP) in endothelial cells.
  • c-Jun NH(2)-terminal kinases (JNKs) are known regulators of c-FLIP expression in endothelial cells, but PEDF's effects on other cell types are not well understood.

Purpose of the Study:

  • To investigate the effect of PEDF on c-FLIP expression in hepatoma cells.
  • To elucidate the signaling pathways involved in PEDF-mediated c-FLIP regulation in hepatoma cells.
  • To determine if PEDF influences the apoptotic response of hepatoma cells.

Main Methods:

  • Semi-quantitative reverse transcriptase (RT)-PCR and immunoblotting were employed to assess c-FLIP expression.
  • Pharmacological inhibitors targeting specific signaling pathways were utilized to examine PEDF signaling involvement.
  • Hepatoma cell line SK-Hep-1 was used to study PEDF effects on c-FLIP and apoptosis.

Main Results:

  • PEDF was found to down-regulate c-FLIP expression in SK-Hep-1 hepatoma cells.
  • PEDF induced p38 kinase phosphorylation in SK-Hep-1 cells, and this effect on c-FLIP was abrogated by a p38 kinase inhibitor.
  • PEDF pretreatment sensitized SK-Hep-1 cells to ciglitazone-induced procaspase-8 cleavage and apoptosis, an effect not mediated by JNK inhibition.

Conclusions:

  • PEDF-induced p38 signaling is responsible for the down-regulation of c-FLIP in SK-Hep-1 cells.
  • PEDF demonstrates a novel role in modulating apoptotic inducible activity within hepatoma cells.
  • These findings suggest a potential therapeutic application of PEDF in liver cancer treatment by enhancing apoptosis.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...